I agree that this site is using cookies. You can find further informations here.
X
Guenther, Margaretha
23  results:
Search for persons X
?
1

Toxicity and adaptive immune response to intracellular tran..:

Mian, Asad ; Guenther, Margaretha ; Finegold, Milton...
Molecular Genetics and Metabolism.  84 (2005)  3 - p. 278-288 , 2005
Link: https://doi.org/10.1016/..
 
?
2

Heterogeneity of RMA-S cell line: derivatives of RMA-S cell..:

Howell, Dewey ; Levitt, Jonathan M. ; Foster, Patricia A....
Immunogenetics.  52 (2000)  1-2 - p. 150-154 , 2000
Link: https://doi.org/10.1007/..
 
?
3

Kinetics of killing by monoclonal cytotoxic T lymphocytes:

Rodgers, John R. ; Shawar, Said M. ; Guenther, Margaretha M..
Journal of Immunological Methods.  152 (1992)  2 - p. 159-169 , 1992
Link: https://doi.org/10.1016/..
 
?
4

MyD88-Dependent Silencing of Transgene Expression During th..:

Suzuki, Masataka ; Cerullo, Vincenzo ; Bertin, Terry K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865218.  , 2010
Link: http://www.ncbi.nlm.nih...
 
?
5

Association of TP53 mutations with TP53 codon 72 polymorphi..:

Foedermayr, Mathilde ; Sebesta, Miriam ; Rudas, Margaretha...
memo - Magazine of European Medical Oncology.  9 (2016)  2 - p. 70-75 , 2016
Link: https://doi.org/10.1007/..
 
?
6

Activity of T-DM1 in Her2-positive breast cancer brain meta..:

Bartsch, Rupert ; Berghoff, Anna S. ; Vogl, Ursula...
Clinical & Experimental Metastasis.  32 (2015)  7 - p. 729-737 , 2015
Link: https://doi.org/10.1007/..
 
?
7

BRCA-1 methylation and TP53 mutation in triple-negative bre..:

Foedermayr, Mathilde ; Sebesta, Miriam ; Rudas, Margaretha...
Cancer Chemotherapy and Pharmacology.  73 (2014)  4 - p. 771-778 , 2014
Link: https://doi.org/10.1007/..
 
?
8

Ovarian function suppression and fulvestrant as endocrine t..:

Bartsch, Rupert ; Bago-Horvath, Zsuzsanna ; Berghoff, Anna...
European Journal of Cancer.  48 (2012)  13 - p. 1932-1938 , 2012
Link: https://doi.org/10.1016/..
 
?
9

Neoadjuvant Chemotherapy Increases the Rate of Breast Conse..:

Fitzal, Florian ; Mittlboeck, Martina ; Steger, Guenther...
Annals of Surgical Oncology.  19 (2011)  2 - p. 519-526 , 2011
Link: https://doi.org/10.1245/..
 
?
10

Predicting for activity of second-line trastuzumab-based th..:

Bartsch, Rupert ; De Vries, Catharina ; Pluschnig, Ursula...
BMC Cancer.  9 (2009)  1 - p. , 2009
Link: https://doi.org/10.1186/..
 
?
11

Factors influencing the time to development of brain metast..:

Fromm, Sabine ; Bartsch, Rupert ; Rudas, Margaretha...
The Breast.  17 (2008)  5 - p. 512-516 , 2008
Link: https://doi.org/10.1016/..
 
?
12

The Austrian fulvestrant registry: results from a prospecti..:

on behalf of the Austrian Fulvestrant Registry ; Bartsch, Rupert ; Mlineritsch, Brigitte...
Breast Cancer Research and Treatment.  115 (2008)  2 - p. 373-380 , 2008
Link: https://doi.org/10.1007/..
 
?
13

Trastuzumab and gemcitabine as salvage therapy in heavily p..:

Bartsch, Rupert ; Wenzel, Catharina ; Gampenrieder, Simon P....
Cancer Chemotherapy and Pharmacology.  62 (2008)  5 - p. 903-910 , 2008
Link: https://doi.org/10.1007/..
 
?
14

Trastuzumab prolongs overall survival in patients with brai..:

Bartsch, Rupert ; Rottenfusser, Andrea ; Wenzel, Catharina...
Journal of Neuro-Oncology.  85 (2007)  3 - p. 311-317 , 2007
Link: https://doi.org/10.1007/..
 
?
15

Results from an observational trial with oral vinorelbine a..:

Bartsch, Rupert ; Wenzel, Catharina ; Altorjai, Gabriela...
Breast Cancer Research and Treatment.  102 (2006)  3 - p. 375-381 , 2006
Link: https://doi.org/10.1007/..
 
1-15